Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (288)
ARTG (239)
Prescription medicine registration (18)

Date

2024 (48)
2023 (47)
2022 (222)
2021 (8)
2020 (33)
2019 (21)
2018 (32)
2017 (11)
2016 (10)
2014 (27)
2013 (17)
2012 (2)
2011 (16)
2010 (19)
2009 (1)
2008 (21)
2007 (5)
2001 (1)
1991 (4)

Results for "[search-keyword]"

Search

Sponsor content

545 result(s) found, displaying 411 to 420

SITAGLIPTIN GENERICHEALTH, SITAGLIPTIN GH, SITAGLIPTIN LAPL (Lupin Australia Pty Limited)

12 November 2018

Prescription medicine registration

Active ingredients: sitagliptin hydrochloride monohydrate.
POSTELLA-1 levonorgestrel 1.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL/ INDAPAMIDE-GA 4/1.25 perindopril erbumine 4mg and indapamide hemihydrate1.25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
CANDESARTAN GH candesartan cilexetil 4 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
CANDESARTAN GH candesartan cilexetil 8 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL-GA perindopril erbumine 2mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL-GA perindopril erbumine 4mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL-GA perindopril erbumine 8mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
Levonorgestrel and ethinylestradiol LAPL 150/30 ED levonorgestrel 150 microgram and ethinylestradiol 30 microgram tablets blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
Levonorgestrel and ethinylestradiol Lupin 150/30 ED levonorgestrel 150 microgram and ethinylestradiol 30 microgram tablets blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited

Pages

First page
Previous page
…
Page 38
Page 39
Page 40
Page 41
Current page 42
Page 43
Page 44
Page 45
Page 46
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.